UM
AMGN icon

Ulysses Management’s Amgen AMGN Stock Holding History

Ulysses Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-30,000
Closed -$4.5M – 45
2016
Q1 		$4.5M Buy
+30,000
New +$4.46M 0.49% 28

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ulysses Management's AMGN Position: Q2 2026 in Review

Ulysses Management opened a new position in Amgen (AMGN) in Q2 2026: 2,000 shares worth $724K. The stake represents 0.14% of the portfolio and ranks #38 among its holdings. This is a return to the name: Ulysses Management previously reported a position in AMGN as recently as Q3 2016.

Ulysses Management first reported a position in AMGN in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.17M in Q3 2016. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ulysses Management held 2,000 shares of Amgen worth $724K as of Q2 2026.
  • Amgen was a new Ulysses Management position in Q2 2026.
  • Amgen made up 0.14% of Ulysses Management's portfolio in Q2 2026, its #38 holding.
  • Ulysses Management first reported a position in Amgen in Q2 2016 and has held it in 3 quarters since.
  • Ulysses Management's Amgen position peaked at $1.17M in Q3 2016.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ulysses Management's 13F filing for Q2 2026, filed 14 Aug 2026.